Search Results 2111-2120 of 20189 for Receptor
Prior treatment with other chemotherapy, radiotherapy (including peptide radionuclide receptor therapy [PRRT]), or surgery must be completed ≥ 28 days prior to ...
ligodendrocyte glycoprotein antibody-associated disease, NMDA receptor antibody encephalitis, Autoimmune epilepsy, Autoimmune encephalitis, Chorea. Show more ...
... receptor agonists.. Bacterial peritonitis within 4 weeks of implant procedure (this includes peritonitis diagnosed at the time of intervention). Serum ...
This finding meant that the molecule's natural inhibitor, the IL-1 receptor antagonist (IL-1Ra), could serve as a promising therapeutic.
... Receptor Suppression Using Integrilin Therapy) Trial. 1994 - present. Specialist InternistSouth African Medical and Dental Council. 1994 - present. FellowSouth ...
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin Cancer Res. 2016 May 1; 22 (9):2301-10 ...
... receptors (CARs). However, developing these NK cells for clinical use has been slowed by difficulty expanding them to sufficient numbers, poor homing to ...
... receptor in the melanocortin-leptin pathway. Since continued assessments of the safety and efficacy of setmelanotide are the same in this extension protocol ...
... receptor alpha (APML-RARA) * MDS with fibrosis (MDS-f) or known prior history of constitutional conditions/syndromes with chemo-responsive AML * Evidence of ...
Participant who has discontinued anti-CGRP (receptor) mAb treatment less than 5 months prior to screening. Prior / concurrent clinical trial experience.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!